iRhythm Holdings (FRA:I25) Total Liabilities: €731.1 Mil (As of Mar. 2026)

What is iRhythm Holdings Total Liabilities?

iRhythm Holdings FRA:I25 -4.76% 20 Total Liabilities is €731.1 Mil as of Mar. 2026. GuruFocus rates FRA:I25 with a GF Score™ of 20/100 and a GF Value™ of €136.67 (Modestly Undervalued). The stock has 1 warning sign investors should review.

iRhythm Holdings's Total Liabilities for the quarter that ended in Mar. 2026 was €731.1 Mil.

iRhythm Holdings's quarterly Total Liabilities declined from Sep. 2025 (€744.07 Mil) to Dec. 2025 (€740.67 Mil) and declined from Dec. 2025 (€740.67 Mil) to Mar. 2026 (€731.06 Mil).

iRhythm Holdings's annual Total Liabilities increased from Dec. 2023 (€204.53 Mil) to Dec. 2024 (€802.72 Mil) but then declined from Dec. 2024 (€802.72 Mil) to Dec. 2025 (€740.67 Mil).

iRhythm Holdings Total Liabilities Related Terms

iRhythm Holdings Total Liabilities Historical Data

* Premium members only.

The historical data trend for iRhythm Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRhythm Holdings Total Liabilities Chart

iRhythm Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

162.36

196.74

204.53

802.72

740.67

iRhythm Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															776.48	745.94	744.07	740.67	731.06

20GF Score

iRhythm Holdings Inc FRA:I25

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

iRhythm Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

iRhythm Holdings's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	129.714	+	(610.181	+	0.77600000000007
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	740.7

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	871.116	-	130.445
	=	740.7

iRhythm Holdings's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	113.964	+	(616.311	+	0.78399999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	731.1

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	870.506	-	139.447
	=	731.1

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of €731.1 Mil mean?

iRhythm Holdings (FRA:I25) has a Total Liabilities of €731.1 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for iRhythm Holdings and its competitors.

Is iRhythm Holdings' Total Liabilities too high?

iRhythm Holdings' current Total Liabilities is €731.1 Mil. Overall, iRhythm Holdings has a GF Score™ of 20/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does iRhythm Holdings' Total Liabilities compare to HAE and LIVN?

iRhythm Holdings' Total Liabilities of €731.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Medical Devices & Instruments company?

A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for iRhythm Holdings and its competitors. iRhythm Holdings's current Total Liabilities is €731.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is iRhythm Holdings stock overvalued right now?

Based on GuruFocus' analysis, iRhythm Holdings (FRA:I25) is currently considered Modestly Undervalued. The stock's GF Value™ is €136.67, compared to a current price of €100.00 — trading 26.8% below its estimated fair value. The current Total Liabilities is €731.1 Mil. iRhythm Holdings' overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For iRhythm Holdings (FRA:I25), the current Total Liabilities is €731.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRhythm Holdings (FRA:I25) Overvalued in 2026?

Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued. The current stock price of €100.00 is trading 26.8% below its estimated GF Value™ of €136.67. GuruFocus considers iRhythm Holdings to be Modestly Undervalued.

Key valuation signals for FRA:I25:

Total Liabilities: €731.1 Mil
GF Value™: €136.67 vs. price of €100.00 (26.8% below fair value)
GF Score™: 20/100 with 1 warning sign

No single metric tells the full story. See the FRA:I25 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRhythm Holdings Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies HAE LIVN ITGR ESTA AXGN TMDX BFLY NEOG UFPT ALMR ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges IRTC:USA 0A7L:UK

Address 699 8th Street, Suite 600, San Francisco, CA, USA, 94103

Website https://www.irhythmtech.com

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

20GF Score

Get the complete analysis for FRA:I25

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€100.00

Price

€136.67

GF Value

View FRA:I25 Analysis

See Total Liabilities data for all stocks →